register

News & Trends - Pharmaceuticals

Season’s Greetings from Health Industry Hub – Pharma, MedTech and Biotech Media

Health Industry Hub | December 23, 2020 |

We trust that Health Industry Hub Pharma, MedTech and Biotech industry news and professional development content is continuing to be meaningful, relevant and enriching your growth. Thank you for your support and your commitment to enhancing your professional and personal development.

If you missed our last e-bulletin for 2020, please click here.

On behalf of Health Industry Hub, we wish you a very Merry Christmas and a peaceful and abundant New Year.

Health Industry Hub will be closed from 21 December 2020 and return on 11 January 2021.

Please send media releases to editor@healthindustryhub.com.au

We look forward to continuing our journey together in 2021 to Connect. Engage. Inspire. Thrive.


News & Trends - Pharmaceuticals

Roche's immunotherapy drug shows promising results for Australian patients with rare blood cancer

Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer

Health Industry Hub | October 8, 2024 |

Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]

More


News & Trends - Pharmaceuticals

Government seals deal with industry for rare cancer therapy

Government seals deal with industry for rare cancer therapy

Health Industry Hub | October 8, 2024 |

Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]

More


News & Trends - MedTech & Diagnostics

Abbott showcases leadless pacemaker system to local stakeholders

Abbott showcases leadless pacemaker system to local stakeholders

Health Industry Hub | October 8, 2024 |

MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]

More


News & Trends - Pharmaceuticals

Australian scientists pivotal in new drug class from BMS

Australian scientists pivotal in new drug class from BMS

Health Industry Hub | October 8, 2024 |

Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]

More


This content is copyright protected. Please subscribe to gain access.